Roche

Bayer's Vividion secures rights to only clinical-stage covalent WRN inhibitor from partner Roche
Fierce Biotech
Wed, 06/4/25 - 11:04 am
Bayer
Vividion Therapeutics
WRN inhibitor
Roche
Roche links BTK inhibitor to low relapse rate across 96-week multiple sclerosis trial
Fierce Biotech
Fri, 05/30/25 - 11:29 am
Roche
fenebrutinib
Btk inhibitors
MS
clinical trials
multiple sclerosis
FDA approves Susvimo for treatment of diabetic retinopathy
Healio
Tue, 05/27/25 - 11:33 am
Roche
Susvimo
diabetic retinopathy
ASCO: Roche, Jazz's Zepzelca small cell lung cancer win leaves room for improvement
Fierce Pharma
Thu, 05/22/25 - 09:29 pm
Roche
Jazz Pharma
Tecentriq
Zepzelca
small cell lung cancer
ASCO 2025
Roche's Genentech sticks with Orionis in 2nd molecular glue deal worth $2B
Fierce Biotech
Wed, 05/21/25 - 11:17 am
Roche
Genentech
Orionis Biosciences
molecular glue
Roche's Columvi expansion bid in danger as FDA's Martin Makary, Richard Pazdur push for more US enrollment in cancer trials
Fierce Pharma
Tue, 05/20/25 - 09:44 pm
Roche
DLBCL
Columvi
FDA
clinical trials
Weighing approval bids from J&J, Pfizer and Roche, FDA scrutinizes data ahead of adcomm
Fierce Pharma
Sun, 05/18/25 - 10:33 pm
FDA
JNJ
Pfizer
Roche
cancer
accomm
Roche to reconsider US investment projects if Trump follows through on pricing order
Fierce Pharma
Wed, 05/14/25 - 10:41 pm
Roche
Donald Trump
most favored nation
drug pricing
Roche reports final overall survival outcomes from breast cancer treatment trial
Clinical Trials Arena
Wed, 05/14/25 - 10:01 am
Roche
clinical trials
breast cancer
Perjeta
Roche plans $700m manufacturing plant in the US
Yahoo Finance
Mon, 05/12/25 - 09:49 pm
Roche
drug manufacturing
obesity
In first oncology expert meeting under Makary, FDA spotlights cancer drugs from J&J, Pfizer, Roche and UroGen
Fierce Pharma
Thu, 05/8/25 - 10:56 pm
FDA
Richard Pazdur
Marty Makary
cancer
oncology
JNJ
Pfizer
Roche
Urogen
Roche in ‘very, very good position’ to weather Trump tariffs, but M&A may suffer
BioSpace
Thu, 04/24/25 - 11:24 am
Roche
earnings
tariffs
Roche looks to a Flagship startup in search of new immune drugs
BioPharma Dive
Wed, 04/23/25 - 09:50 am
Roche
Repertoire Immune Medicines
Genentech
autoimmune disease
Roche to invest $50 billion in the U.S. as pharma tariff threat lingers
CNBC
Tue, 04/22/25 - 11:10 am
Roche
tariffs
drug manufacturing
In Bay Area, Gilead cuts 149 positions and Roche's diagnostics division lays off 108
Fierce Pharma
Mon, 04/7/25 - 11:22 pm
Gilead Sciences
Roche
layoffs
California
Sarepta and Roche aim to resume paused Elevidys trials following patient death
Clinical Trials Arena
Mon, 04/7/25 - 11:35 am
Sarepta Therapeutics
Roche
Elevidys
clinical trials
DMD
patient deaths
Roche preps phase 3 for 'Brainshuttle' Alzheimer's drug
Pharmaphorum
Mon, 04/7/25 - 10:05 am
Roche
clinical trials
Alzheimer's disease
trontinemab
The top 10 pharma R&D budgets for 2024
Fierce Biotech
Fri, 04/4/25 - 11:30 am
R&D
Merck
JNJ
Roche
AstraZeneca
AbbVie
Bristol Myers Squibb
Eli Lilly
Pfizer
Novartis
Sanofi
Sarepta’s Duchenne Gene Therapy Placed on Hold in Europe Pending Death Investigation
BioSpace
Thu, 04/3/25 - 11:26 am
Sarepta Therapeutics
Roche
gene therapy
patient deaths
Europe
Eleviys
DMD
With biosimilar competition looming, Roche takes a hit with failure of high-dose Ocrevus
Fierce Pharma
Wed, 04/2/25 - 07:36 pm
Ocrevus
multiple sclerosis
Roche

Pages